2023
Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study
Phillips M, Antillon M, Bilcke J, Bar-Zeev N, Limani F, Debellut F, Pecenka C, Neuzil K, Gordon M, Thindwa D, Paltiel A, Yaesoubi R, Pitzer V. Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study. BMC Infectious Diseases 2023, 23: 143. PMID: 36890448, PMCID: PMC9993384, DOI: 10.1186/s12879-023-08105-2.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentCost-Benefit AnalysisCost-Effectiveness AnalysisHumansTyphoid FeverTyphoid-Paratyphoid VaccinesVaccines, ConjugateConceptsTyphoid Conjugate VaccineRoutine vaccinationReactive vaccinationVaccination strategiesOutbreak settingsMultidrug-resistant Salmonella typhiQueen Elizabeth Central HospitalTyphoid fever epidemicYears of ageMonths of ageCost-effectiveness analysisWorld Health OrganizationConjugate vaccineCentral HospitalRoutine immunizationVaccine deploymentPreventive vaccinationVaccinationTyphoid feverCost-effective strategyAge 15Health OrganizationFever epidemicAntimicrobial resistanceOutbreak definitions
2019
Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study
Arifin SMN, Zimmer C, Trotter C, Colombini A, Sidikou F, LaForce FM, Cohen T, Yaesoubi R. Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study. Medical Decision Making 2019, 39: 553-567. PMID: 31268405, PMCID: PMC6786941, DOI: 10.1177/0272989x19859899.Peer-Reviewed Original ResearchConceptsReactive campaignsSerogroup replacementConjugate vaccineOne-time catchPolyvalent meningococcal vaccineRoutine infant vaccinationMeningococcal conjugate vaccineMeningococcal polysaccharide vaccineRoutine infant immunizationCurrent vaccination practicesImportant health benefitsCost-effectiveness thresholdStandard cost-effectiveness thresholdsAgent-based transmission modelVaccination seriesImmunization seriesInfant vaccinationInfant immunizationPolysaccharide vaccineMeningococcal vaccineVaccination practicesPolyvalent vaccineLaboratory confirmationMenAfriVacSerogroups APredicting the Impact of Typhoid Conjugate Vaccines on Antimicrobial Resistance
Kaufhold S, Yaesoubi R, Pitzer VE. Predicting the Impact of Typhoid Conjugate Vaccines on Antimicrobial Resistance. Clinical Infectious Diseases 2019, 68: s96-s104. PMID: 30845324, PMCID: PMC6405272, DOI: 10.1093/cid/ciy1108.Peer-Reviewed Original ResearchConceptsChronic carriersAntimicrobial-resistant infectionsProportion of casesTyphoid-endemic settingsTyphoid infectionVaccination coverageResistant infectionsFuture vaccination campaignsOne-way sensitivity analysesTyphoid Conjugate VaccineTransmission dynamic modelSalmonella enterica serovar TyphiEmpiric prescribingConjugate vaccineEnterica serovar TyphiIntroduction of typhoidTreatment strategiesVaccination campaignTotal casesHealth outcomesNumber of casesRate of recoveryInfectionResistant strainsTotal number
2018
The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study
Yaesoubi R, Trotter C, Colijn C, Yaesoubi M, Colombini A, Resch S, Kristiansen PA, LaForce FM, Cohen T. The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study. PLOS Medicine 2018, 15: e1002495. PMID: 29364884, PMCID: PMC5783340, DOI: 10.1371/journal.pmed.1002495.Peer-Reviewed Original ResearchMeSH KeywordsBurkina FasoCost-Benefit AnalysisHealth PolicyImmunization ProgramsMeningococcal VaccinesModels, TheoreticalVaccinationVaccines, ConjugateConceptsDisability-adjusted life yearsMeningococcal casesConjugate vaccineMeningitis beltVaccination strategiesMeningococcal serogroupsStrain replacementNationwide immunization campaignPolyvalent meningococcal vaccineMeningococcal conjugate vaccineCurrent World Health OrganizationAfrican meningitis beltAlternative vaccination strategiesAlternative vaccination policiesWorld Health OrganizationMeningococcal transmissionReactive campaignsMeningococcal vaccineImmunization campaignVaccination policyPolyvalent vaccineMeningitis epidemicsReactive vaccinationVaccine policyVaccine price